Status:
COMPLETED
Methadone Monitoring for Insights Into Adverse Events
Lead Sponsor:
Intermountain Health Care, Inc.
Conditions:
Pain
Opiate Addiction
Eligibility:
All Genders
18+ years
Brief Summary
Methadone has been an effective and inexpensive therapy in the management of chronic pain and opioid dependence. However it has been associated with sudden, unexpected deaths. Two mechanisms have been...
Eligibility Criteria
Inclusion
- must be 18 years of age or older; eligible for methadone treatment as judged by Discovery House criteria
- must sign informed consent for methadone treatment prior to being approached for this study
- must sign a written informed consent for this study
- is willing and has a means to return for all scheduled follow-up visits
Exclusion
- pregnancy, participation in any other clinical trial involving investigational or marketed products with 30 days prior to entry into this study; current use of an inducer/inhibitor of known enzymes involved with methadone metabolism
- use of methadone in the 30 days prior to study enrollment; concomitant use of QT prolonging drugs
- considered by the treatment physician to be ineligible for methadone treatment; hepatic function panel indicates chronic liver disease.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01191242
Start Date
August 1 2010
End Date
May 1 2011
Last Update
March 29 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Intermountain Medical Center
Murray, Utah, United States, 84107
2
Discovery House
Taylorsville, Utah, United States, 84123